| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/18/2001 | WO2001003697A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 01/18/2001 | WO2001003688A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 01/18/2001 | WO2001003685A2 Novel prodrugs for antimicrobial amidines |
| 01/18/2001 | WO2001003681A2 Use of flavones, coumarins and related compounds to treat infections |
| 01/18/2001 | WO2001003667A1 Delivery system for biological material |
| 01/18/2001 | WO2001003656A1 Antimicrobial artificial nail composition and methods for preparing and using same |
| 01/18/2001 | WO2000063225A3 Macrolide antiinfective agents |
| 01/18/2001 | WO2000063224A3 Macrolide antiinfective agents |
| 01/18/2001 | WO2000062793A3 Pseudomycin antifungal compositions and methods for their use |
| 01/18/2001 | WO2000062744A3 Skin care compositions containing combination of skin care actives |
| 01/18/2001 | WO2000060050A3 Recombinant influenza viruses for vaccines and gene therapy |
| 01/18/2001 | WO2000057904A3 Attenuated dengue-3 virus vaccine |
| 01/18/2001 | WO2000053213A3 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 01/18/2001 | WO2000051631A3 Pegylated alpha interferon for hiv therapy |
| 01/18/2001 | WO2000043014A8 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 01/18/2001 | WO2000039304A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/18/2001 | DE19933173A1 Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶ |
| 01/18/2001 | CA2801979A1 Antigenic meningococcal peptides |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2379362A1 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2379012A1 In vitro reconstitution of segmented negative-strand rna viruses |
| 01/18/2001 | CA2379010A1 Methods of inducing cell death |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378661A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | CA2378653A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | CA2378600A1 Amino ceramide-like compounds and therapeutic methods of use |
| 01/18/2001 | CA2378595A1 Benzoylpyridazines |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378562A1 Method for producing oligopolysaccharides |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378402A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2378014A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 01/18/2001 | CA2377902A1 Novel prodrugs for antimicrobial amidines |
| 01/18/2001 | CA2377677A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 01/18/2001 | CA2377674A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 01/18/2001 | CA2375647A1 Use of flavones, coumarins and related compounds to treat infections |
| 01/18/2001 | CA2374411A1 Novel esters derived from nucleosides, preparation methods and pharmaceutical compositions containing them |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1068871A1 Novel methods and medicament for treating infections diseases involving microbial biofilms |
| 01/17/2001 | EP1068331A1 Medicaments for inducing cytotoxic t-cells |
| 01/17/2001 | EP1068329A2 FUSION PROTEINS OF $i(MYCOBACTERIUM TUBERCULOSIS) ANTIGENS AND THEIR USES |
| 01/17/2001 | EP1068328A1 Treatment and diagnosis of staphylococcal infections |
| 01/17/2001 | EP1068314A1 Highly active forms of interferon regulatory factor proteins |
| 01/17/2001 | EP1068297A1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 01/17/2001 | EP1068229A1 Peptides |
| 01/17/2001 | EP1068223A1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068219A1 Acylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| 01/17/2001 | EP1068215A1 Azt derivatives exhibiting spermicidal and anti-viral activity |
| 01/17/2001 | EP1068212A1 THIAZOLO 4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS |
| 01/17/2001 | EP1068210A2 Process for the production of purine derivatives |
| 01/17/2001 | EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES |
| 01/17/2001 | EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors |
| 01/17/2001 | EP1068205A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands |
| 01/17/2001 | EP1068200A1 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 01/17/2001 | EP1068189A1 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors |
| 01/17/2001 | EP1068182A1 Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one |
| 01/17/2001 | EP1068180A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloprotenase inhibitors |
| 01/17/2001 | EP1067963A1 Hiv-specific cytotoxic t-cell responses |
| 01/17/2001 | EP1067962A2 Derivatives of pneumococcal choline binding proteins for vaccines |
| 01/17/2001 | EP1067952A1 Methods for treatment and prevention of infections |
| 01/17/2001 | EP1067948A1 Use of extracts of bearberry leaves (arctostaphylos uva ursi), birch leaves (betula), horsetail (equisetum) and stinging nettle (urtica) |
| 01/17/2001 | EP1067947A1 Use of extracts of echinacea pallida and echinacea angustifolia, dandelion (taraxacum) and plantain (plantago) |
| 01/17/2001 | EP1067946A1 Anti-bacterial protein extracts from seeds of marigold and paprika |
| 01/17/2001 | EP1067944A1 New combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 01/17/2001 | EP1067936A1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants |
| 01/17/2001 | EP1067915A2 Device for the transdermal delivery of diclofenac |
| 01/17/2001 | EP1067897A1 An acidified composition for topical treatment of nail and skin conditions |
| 01/17/2001 | EP0971889A4 Process for synthesizing carbapenem intermediates |
| 01/17/2001 | CN1280620A Antigen protein and nucleic acid coding for said protein |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280585A Novel 3.6-hemiketals from the class of 9a-azalides |
| 01/17/2001 | CN1280580A Thienopyrimidine and thienopyridine derivatives useful as anti-cancer agents |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280504A Vaccines with an LTB adjuvant |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/17/2001 | CN1279953A Application of seeweed polyose sulphate |
| 01/17/2001 | CN1279945A Gastric floating slow-releasing tinidazole capsule and its preparing method |
| 01/17/2001 | CN1279944A Effervescent tablets for curing vaginitis and its preparing method |
| 01/17/2001 | CN1060781C Phosphonomonoester nucleic acids, process for treir preparation, and their use |
| 01/17/2001 | CN1060778C Cephalosporin derivatives |
| 01/17/2001 | CN1060770C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| 01/16/2001 | US6174994 7TM receptor (H2CAA71) |
| 01/16/2001 | US6174896 Quinuclidine derivatives and medicinal composition thereof |
| 01/16/2001 | US6174895 1-aryl-3-arylmethyl-1,8-naphthyridin-4(1H)-ones |
| 01/16/2001 | US6174868 Compositions and methods for treatment of hepatitis C virus-associated diseases |
| 01/16/2001 | US6174867 Inhibition of the binding of a toxin or organism to its corresponding cell surface receptor; e.g., heat-labile enterotoxin or cholera toxin or enterovirulent organisms; bactericides, viricides, fungicides |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174714 Lyss |
| 01/16/2001 | US6174685 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use |
| 01/16/2001 | US6174666 Reducing adjustments in ribonucleic acid sequences; providing gene coding transcription products, detect regulatory sequences, insert point mutations, transfect mutated gene into cells, culture cells and monitoring gene expression |
| 01/16/2001 | US6174532 L2 immunogenic peptides of papillomavirus |
| 01/16/2001 | US6174528 Inducing protective antibodies against group a streptococci |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |